Caris Life Sciences, Inc. (CAI) Form 10-Q Quarterly Reports
Caris Life Sciences, Inc. (CAI) is a publicly traded company on the Nasdaq, categorized under SIC 8071 (Services-Medical Laboratories). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CAI
CIK: 2019410
Exchange: Nasdaq
SIC 8071: Services-Medical Laboratories
Fiscal Year End: 12/31
State: TX
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerDremeco Seifert
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-23 | 2026-09-22 | FORM 4 | 0002071923-26-000007 | View SEC Doc Filr Page |
| 144 | 2026-09-22 | — | 144 Filing | 0001950047-26-009733 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-17 | FORM 4 | 0002071959-26-000008 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001950047-26-009640 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | 8-K | 0002019410-26-000061 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-03 | FORM 4 | 0002071953-26-000007 | View SEC Doc Filr Page |
| 144 | 2026-09-04 | — | 144 Filing | 0001950047-26-009157 | View SEC Doc Filr Page |
| 144 | 2026-09-03 | — | 144 Filing | 0001950047-26-009094 | View SEC Doc Filr Page |
| 144 | 2026-08-24 | — | 144 Filing | 0001950047-26-008599 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-14 | FORM 4 | 0001239594-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-14 | FORM 4 | 0001239690-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-14 | FORM 4 | 0002038687-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-14 | FORM 4 | 0001705850-26-000025 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-14 | FORM 4 | 0002071948-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-14 | FORM 4 | 0001724161-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-14 | FORM 4 | 0001189395-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-14 | FORM 4 | 0001189394-26-000008 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000905148-26-003576 | View SEC Doc Filr Page |
| 144 | 2026-08-07 | — | 144 Filing | 0001950047-26-007834 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-07 | — | SCHEDULE 13G/A Filing | 0001193125-26-340353 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0002019410-26-000055 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0002019410-26-000053 | View SEC Doc Filr Page |
| 144 | 2026-08-03 | — | 144 Filing | 0001950047-26-007491 | View SEC Doc Filr Page |
| 4 | 2026-07-13 | 2026-05-15 | FORM 4 | 0001189394-26-000005 | View SEC Doc Filr Page |
| CERT | 2026-06-16 | — | NYSE TEXAS CERTIFICATION | 0000876882-26-000010 | View SEC Doc Filr Page |